Otrasa
Otrasa is indicated for the treatment of adult & Paediatric patients with:
Chronic myeloid leukaemia (CML)
Acute lymphoblastic leukaemia (ALL)
Strength:
20 mg
50 mg
70 mg
80 mg
100 mg
140 mg
Dosage Form:
Film-Coated Tablets
Active ingredient:
Dasatinib.
Imatinib SPC
Imatinib SPC is indicated for the treatment of:
Philadelphia chromosome positive Chronic myeloid leukaemia (CML).
Philadelphia
chromosome positive acute lymphoblastic leukaemia (Ph-positive
ALL).
Gastro-intestinal Stromal Tumor
(GIST)
Strength:
100 mg
400 mg
Dosage Form:
Film-Coated Tablets
Active ingredient:
Imatinib.
Azacitidine SPC
Azacitidine SPC is used in adults who are not able to have a stem cell transplantation to treat:
myelodysplastic syndromes (MDS).
acute myeloid leukaemia (AML)
Strength:
100 mg
Dosage Form:
Vial for injection
Active ingredient:
Azacitidine.
